CCL2 and metabolic syndrome: Moreover, serum CCL2 (monocyte chemoattractant protein-1, MCP-1) expression is elevated in MetS (85), and CCL2 has the potential to activate the p38 MAPK pathway via CCR2, which causes BBB breakage (86).